Genomic-scale prioritization of drug targets: the TDR Targets database

The increasing availability of genomic data for pathogens that cause tropical diseases has created new opportunities for drug discovery and development. However, if the potential of such data is to be fully exploited, the data must be effectively integrated and be easy to interrogate. Here, we discuss the development of the TDR Targets database (http://tdrtargets.org), which encompasses extensive genetic, biochemical and pharmacological data related to tropical disease pathogens, as well as computationally predicted druggability for potential targets and compound desirability information. By allowing the integration and weighting of this information, this database aims to facilitate the identification and prioritization of candidate drug targets for pathogens.

[1]  S. Beverley,et al.  Development of a safe live Leishmania vaccine line by gene replacement. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Ken Blanchard,et al.  Mission Possible , 1999 .

[3]  Ronald W. Davis,et al.  Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.

[4]  J. Varghese,et al.  Development of neuraminidase inhibitors as anti‐influenza virus drugs , 1999 .

[5]  Peter M Woollard,et al.  Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence. , 2002, Microbiology.

[6]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[7]  Y. Dong,et al.  Systematic functional analysis of the Caenorhabditis elegans genome using RNAi , 2003, Nature.

[8]  Karl W. Broman,et al.  A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: Application to Mycobacterium tuberculosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. W. Campbell,et al.  Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655 , 2003, Journal of bacteriology.

[10]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.

[11]  E. Oldfield,et al.  Farnesyl Pyrophosphate Synthase Is an Essential Enzyme in Trypanosoma brucei , 2003, The Journal of Biological Chemistry.

[12]  D. Roos,et al.  Purine Salvage Pathways in the Apicomplexan Parasite Toxoplasma gondii* , 2004, Journal of Biological Chemistry.

[13]  Marc A. Martí-Renom,et al.  MODBASE: a database of annotated comparative protein structure models and associated resources , 2005, Nucleic Acids Res..

[14]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[15]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[16]  Feng Chen,et al.  OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups , 2005, Nucleic Acids Res..

[17]  Samiul Hasan,et al.  Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis , 2006, PLoS Comput. Biol..

[18]  Solomon Nwaka,et al.  Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.

[19]  O. Heby,et al.  Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas’ disease, and leishmaniasis , 2007, Amino Acids.

[20]  Fangfang Xia,et al.  The National Microbial Pathogen Database Resource (NMPDR): a genomics platform based on subsystem annotation , 2006, Nucleic Acids Res..

[21]  P. Gilson,et al.  Molecular genetic tools in Toxoplasma and Plasmodium: achievements and future needs. , 2007, Current opinion in microbiology.

[22]  A. Hopkins,et al.  Mission possible , 2002, Nature.

[23]  J. Vermunt,et al.  Assessing Performance of Orthology Detection Strategies Applied to Eukaryotic Genomes , 2007, PloS one.

[24]  Jonathan E. Allen,et al.  Draft Genome of the Filarial Nematode Parasite Brugia malayi , 2007, Science.

[25]  J. Foster,et al.  Mining Predicted Essential Genes of Brugia malayi for Nematode Drug Targets , 2007, PloS one.

[26]  John P. Overington,et al.  Chapter 36. The Molecular Basis of Predicting Druggability , 2008 .

[27]  S. Yokoyama,et al.  Contribution of structural biology to clinically validated target proteins. , 2008, Drug discovery today.